Let Me Tell You More About My Depressed, Miserable Existence
By Depressed Jane on September 6, 2006
Individuals with major depression have an exaggerated inflammatory response to psychological stress compared to those who do not suffer from depression, according to a study by researchers at Emory University School of Medicine. [click link for full article]
Popularity: unranked [?]
By Depressed Jane on September 6, 2006
Bipolar disorder costs twice as much in lost productivity as major depressive disorder, a study funded by the National Institutes of Health’s (NIH) National Institute of Mental Health (NIMH) has found. Each U.S. worker with bipolar disorder averaged 65.5 lost workdays in a year, compared to 27.2 for major depression. Even though major depression is more than six times as prevalent, bipolar disorder costs the U.S. workplace nearly half as much – a disproportionately high $14. [click link for full article]
Popularity: unranked [?]
By Depressed Jane on September 6, 2006
Multiple sclerosis (MS) is a disease that affects the cells of the brain and spinal cord. MS can cause various symptoms, including depression, pain, and impaired mobility. Although it is clear that MS is caused by cells of the immune system inappropriately attacking the cells of the brain and spinal cord, much remains unknown about the disease. [click link for full article]
Popularity: unranked [?]
By Depressed Jane on September 6, 2006
Memory Pharmaceuticals Corp. (Nasdaq: MEMY) today announced the dosing of the first subject in a Phase 2a trial of MEM 1003 in patients with acute mania in bipolar disorder. The Company is conducting the trial as part of itsagreement with The Stanley Medical Research Institute (SMRI), which isproviding funding support for this Phase 2a clinical trial of MEM 1003. [click link for full article]
Popularity: unranked [?]
By Depressed Jane on September 4, 2006
Wyeth (NYSE:WYE) announced today it has been notified by the U.S. Food and Drug Administration (FDA) that the agency has extended by three months the action date for its review of the New Drug Application (NDA) for desvenlafaxine succinate extended release for the treatment of major depressive disorder. The FDA’s revised action date for the NDA for desvenlafaxine succinate will now be January 22, 2007. [click link for full article]
Popularity: unranked [?]
By Depressed Jane on September 3, 2006
Most people who seek help for depression first visit their primary care doctors. So these professionals, along with mental health professionals and insurers, have been looking for ways to better identify and treat depression in the primary care setting, reports the September issue of the Harvard Mental Health Letter. [click link for full article]
Popularity: unranked [?]
By Depressed Jane on September 2, 2006
Cardiovascular diseases (CVD) and affective disorders are both very prevalent in the general population. However, it is unclear on a population level if the prevalence of different subtypes of affective disorders like unipolar major depression or dysthymia is different in individuals with specific CVDs. This has been investigated in a paper published in the Sept issue of Psychotherapy and Psychosomatics. [click link for full article]
Popularity: unranked [?]
By Depressed Jane on September 2, 2006
A new study released today in theAmerican Journal of Psychiatry examines the impact depression has on workproductivity. The study, conducted by researchers at Tufts-New EnglandMedical Center, compared depressed employees with two groups: those withrheumatoid arthritis (RA), which is a condition associated with workdisability, and depression-free healthy employees. [click link for full article]
Popularity: unranked [?]
